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Abstract
Introduction: We report an unusual case of Wilson’s disease that was revealed by presentation of leptospirosis.
The prompt detection of this potentially life-threatening disease highlights the importance of careful investigation.
To the best of our knowledge, this is the first reported case of leptospirosis involving the development of
fulminant liver failure due to Wilson’s disease.
Case presentation: A 17-year-old Caucasian woman presented with fever, rigors, vomiting and scleral jaundice.
Following clinical and laboratory evaluation she was diagnosed with leptospirosis. After remission of this disease
her condition inexplicably deteriorated. Further investigations revealed that she had Wilson’s disease.
Conclusions: The unexplained deterioration of hepatic function in a young person in remission from leptospirosis
should alert the clinician to the presence of an underlying disorder, such as Wilson’s disease, the early detection of
which is crucial to the prognosis. The mechanism that initiates the development of Wilson’s disease is not fully
understood, but it is thought that an intercurrent illness, such as viral infection or drug toxicity, could be
implicated. In our case, leptospirosis appeared to precipitate the deterioration of liver function in a patient with
Wilson’s disease, advancing our knowledge of this association. This original case report could have a broader
clinical impact across medicine.
Introduction
Leptospirosis is a zoonosis with protean manifestation
caused by the spirochete, Leptospira interrogans.I ti s
usually characterized by sudden onset of fever, rigors,
myalgias and headache and is occasionally accompanied
by nausea, vomiting and diarrhea. The disease course is
generally mild to moderate and is seldom complicated
by liver failure [1]. Wilson’sd i s e a s ei sar a r ec a u s eo f
liver disorder, whose clinical manifestations range from
increased levels of aminotransferase and bilirubin,
decreased serum ceruloplasmin and detectable Kayser-
Fleischer rings to fulminant hepatic failure (FHF). It can
also present with neurologic, hematologic and renal dys-
function and affects mainly females between five and 40
years of age. This typical presentation represents only
50 percent of patients ultimately diagnosed with Wil-
son’s disease [2]. To our knowledge, an association
between leptospirosis and Wilson’s disease has not been
reported.
Case presentation
A 17-year-old Caucasian woman was admitted to the
hospital following a seven-day history of malaise, with a
temperature of 39°C, chills, anorexia, vomiting and
scleral jaundice. Two days earlier she had discontinued
treatment of norethisterone (Primolut-Nor), prescribed
for polycystic ovaries. She was a resident of Athens, did
not consume alcohol or take any illicit drugs and had
not been exposed to rat excrement. Physical examina-
tion revealed a temperature of 38.8°C and mild
epigastric tenderness on palpation without hepatosple-
nomegaly or mass. Apart from being jaundiced, there
were no other signs of liver disease. Slurring of speech
was evident on neurologic examination. There were no
other clinical findings. White-cell count was 16,770/cm
3,
with 80% neutrophils; hemoglobin level was 9.4 g/dL,
hematocrit 28.3%, with a normal mean corpuscular
* Correspondence: andreadise@ath.forthnet.gr
3rd Department of Internal Medicine “Evangelismos” State General Hospital,
Athens, Greece
Andreadis et al. Journal of Medical Case Reports 2010, 4:256
http://www.jmedicalcasereports.com/content/4/1/256 JOURNAL OF MEDICAL
CASE REPORTS
© 2010 Andreadis et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.volume and 6% reticulocytes; platelet count was
240,000/cm
3 and erythrocyte sedimentation rates
36 mm/h. Analysis of the peripheral-blood smear
showed a normal differential count with no band forms,
basophilic stippling, or schistocytes. Coagulation profile:
international normalized ratio (INR) 2.76, activated par-
tial-thromboplastin time (aPTT) 72.11 s. Biochemistry
findings showed 49 mg/dL glucose, 0.79 mg/dL serum
creatinine, 2.8 g/dL albumin, 32 IU/L alkaline phospha-
tase (normal range 35 to 104), 33 IU/L alanine amino-
transferase (normal range 5 to 40), 140 IU/L aspartate
aminotransferase (normal range 5 to 37), 27.79 mg/dL
total serum bilirubin (normal value < 1), 16.44 mg/dL
direct bilirubin (normal value < 0.25), and 184 IU/L
g-glutamyltransferase (normal range 7 to 32). Tests for
hepatitis C virus antibody (anti-HCV), hepatitis B
(HBsAg, HBeAg, anti-HBc and anti-HBs), and hepatitis
A antibody were negative, as were tests for antibodies
against cytomegavirus (CMV), human immunodeficiency
virus (HIV) types 1 and 2, anti-nuclear (ANA) and anti-
mitochondrial (AMA) antibodies. A serum acetamino-
phen level was undetectable. Blood cultures obtained at
admission were negative. Serologic test for Leptospira
interrogans was positive (IgM > 1:80). Treatment was
initiated with penicillin G 40,000 units/kg/day for seven
days. Although our patient became afebrile, her mental
status deteriorated and she displayed drowsiness and
flapping tremor. Total serum bilirubin increased further
to 66.7 mg/dL, INR reached 7.7 and ammonia (NH3)
rose to 95.7 μmol/L (normal range 11 to 51). Hemolysis
caused the hematocrit (Ht) level to drop to 17.6%. A
Coombs’ test was negative. No signs of bleeding were
present. Lactulose and neomycin was administered and
our patient received a transfusion of packed red blood
cells, fresh frozen plasma and glucose. She was also
given vitamin K but her coagulopathy remained unre-
sponsive. Our patient appeared to have fulminant hepa-
tic failure (FHF) with a Nazer score of eight in
accordance with the prognostic index [3]. As the score
was relatively high, she was referred to the National
Transplant Organization for evaluation. It was decided
that she was eligible for emergency liver transplantation
and she was transferred abroad. However, within 20
days her clinical and biochemical condition showed
signs of recovery and she was sent back to our depart-
ment. A subsequent relapse prompted further investiga-
tion. Serologic test for Leptospira interrogans was
repeated which showed lower levels of IgM antibodies
(1/20). Having excluded the most common causes of
acute liver failure, such as hepatitis A, B or drugs, it was
reasonable to seek a less common etiology. In our
young patient, the combination of neurological disorder,
non autoimmune hemolytic anemia and unexplained
liver disease along with negative Coombs, coagulopathy
unresponsive to vitamin K, serum aminotransferases less
than 2000 IU/L and normal or markedly subnormal
alkaline phosphatase (< 40 IU/L), all suggested Wilson’s
disease. According to guidelines from the American
Association for the Study of Liver Diseases (AASLD)
patients in whom Wilson’s disease is suspected should
undergo screening with serum ceruloplasmin, 24-hour
basal urinary copper, and slit-lamp examination for Kay-
ser-Fleischer rings [1]. In our case, serum ceruloplasmin
concentration was very low (7.0 mg/dL), and the
Figure 1 Kayser-Fleisher ring in a 17-year-old woman with Wilson’s disease.
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Page 2 of 324-hour urinary copper excretion was 11,700 mcg (nor-
mal values ≤ 40 mcg). Slit-lamp examination detected
Kayser-Fleischer rings (Figure 1). Given the deteriora-
tion in our patient’s condition she was treated with a
combination of zinc, which induces a negative copper
balance by blocking intestinal absorption, and trientine,
which acts as a potent copper chelator. Our patient
showed gradual signs of improvement.
Discussion
This case highlights the need for increased awareness in
patients presenting with leptospirosis and liver disease,
when the apparent remission of leptospirosis does not
concur with improvement of liver function. The dete-
rioration of our patient’s clinical condition and the bio-
chemical findings strongly point to an underlying
disease that was not obvious at the initial presentation.
Since other causes of FHF including viral, toxin or
immunologic disease were excluded, the diagnosis of
Wilson’s disease underlying leptospirosis appeared more
likely. The three most relevant features that characterize
Wilson’s disease include age < 35 years, Coombs nega-
tive hemolytic anemia and low serum alkaline phospha-
tase level, all of which applied to our patient. Diagnosis
was established on the basis of Kayser-Fleischer rings,
serum ceruloplasmin levels below 20 mg/dL and 24-
hour urinary copper in excess of 40 mcg [4]. Massive
release of copper from necrotic hepatocytes can display
normal copper tissue concentration, as a result of which
a biopsy sample could render false negative results. Hav-
ing reached diagnosis in our case, liver biopsy proved
unnecessary; our patient had FHF as defined by the
development of acute hepatitis and encephalopathy in a
person with no history of liver disease [5].
Conclusions
The clinician should suspect an underlying disease in an
unexplained liver failure associated with leptospirosis.
The unexplained deterioration of hepatic function in a
young person in remission from leptospirosis should
alert the clinician to the presence of an underlying dis-
order, such as Wilson’s disease, the early detection of
which is crucial to the prognosis. As the literature has
no documented reports of a leptospirosis infection being
susceptible to severe liver disease, this case encourages
further investigation.
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